GPX4 and ovarian cancer: Specifically, the percentage of SLC7A11 high‐expression ovarian cancer tissues with a high GPX4 expression was 60.47% (26/43 cases), whereas it was only 12.08% (18/149 cases) in SLC7A11 low‐expression tissues; this difference was statistically significant (p < 0.001).